Pages that link to "Q45291700"
Jump to navigation
Jump to search
The following pages link to Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity (Q45291700):
Displaying 31 items.
- Dopamine Receptors and Neurodegeneration (Q26783348) (← links)
- Iron dysregulation in Huntington's disease (Q26829932) (← links)
- Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies (Q28072353) (← links)
- Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model (Q28265056) (← links)
- Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment (Q30315395) (← links)
- Calcium-activated calpain-2 is a mediator of beta cell dysfunction and apoptosis in type 2 diabetes (Q33581290) (← links)
- Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model (Q33786465) (← links)
- In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects (Q33980357) (← links)
- Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice (Q34017941) (← links)
- Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives (Q34426072) (← links)
- Striatal synaptic dysfunction and hippocampal plasticity deficits in the Hu97/18 mouse model of Huntington disease (Q35146890) (← links)
- Neurodegenerative processes in Huntington's disease (Q35572092) (← links)
- Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease (Q37311202) (← links)
- The role of striatal NMDA receptors in drug addiction (Q37629984) (← links)
- Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease (Q37776087) (← links)
- Brain networks in Huntington disease (Q37834193) (← links)
- Screening of therapeutic strategies for Huntington's disease in YAC128 transgenic mice. (Q37866383) (← links)
- Involvement of kynurenines in Huntington's disease and stroke-induced brain damage (Q37892975) (← links)
- Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function. (Q37930190) (← links)
- Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease (Q37996350) (← links)
- From pathways to targets: understanding the mechanisms behind polyglutamine disease. (Q38259591) (← links)
- Downregulation of NF-kappaB signaling by mutant huntingtin proteins induces oxidative stress and cell death (Q38345681) (← links)
- Calcium signaling and neurodegenerative diseases (Q39463322) (← links)
- Calcium signaling and neurodegeneration. (Q42066419) (← links)
- Decreasing Levels of the cdk5 Activators, p25 and p35, Reduces Excitotoxicity in Striatal Neurons (Q42108493) (← links)
- Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain (Q43021497) (← links)
- Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease. (Q45297446) (← links)
- Cause or compensation?-Altered neuronal Ca2+ handling in Huntington's disease. (Q50088379) (← links)
- Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice (Q57459208) (← links)
- Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition (Q58700269) (← links)
- Altered Regulation of Striatal Neuronal -Methyl-D-Aspartate Receptor Trafficking by Palmitoylation in Huntington Disease Mouse Model (Q64119320) (← links)